Cure8 research brief
Anemia is common in IBD and hard to classify accurately; better blood markers can guide appropriate iron treatment and avoid delays. This study evaluates a novel marker (sHjv) alongside established tests.
Clinicians managing anemia in IBD, researchers studying biomarkers for iron disorders in chronic inflammation, and adult IBD patients concerned about anemia evaluation.
Researchers measured standard iron markers (transferrin saturation, soluble transferrin receptor [sTFR], sTFR index) and hepcidin, plus serum hemojuvelin (sHjv), in 152 consecutive IBD patients. The sTFR and especially the sTFR index performed well for identifying true iron deficiency anemia.
By contrast, sHjv did not show useful diagnostic performance for IDA, although it correlated negatively with hepcidin.
Takeaway If you or your clinician are looking for blood tests to help tell iron deficiency from inflammation-driven anemia in IBD, this study supports the value of sTFR and the sTFR index; it does not support adding sHjv as a diagnostic marker based on the presented data.
Structured content depth: abstract. The brief is based on the article abstract provided by the journal; Cure8 did not review the full peer-reviewed article beyond the supplied abstract.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
A blood biomarker (OSM) that tracks microscopic inflammation could help detect residual disease activity that fecal calprotectin and routine clinical scores miss. That matters because histological inflammation predicts...
Non-invasive biomarkers that reflect mucosal inflammation and systemic disease activity could help reduce reliance on frequent endoscopy and guide monitoring for people with Crohn’s disease or ulcerative colitis.
Sarcopenia is common in Crohn's disease and is linked to worse outcomes; a simple GNRI-based prediction tool could help identify at-risk patients without routine CT scanning.
